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We are writing as scientists and editors of leadingpeer-reviewed journals that have published impor-
tant contributions in the study of endocrine disrupting
chemicals (EDCs). By signing this editorial, we affirm that
regulatory decisions on EDCs should be made based on
the best available science and expertise that involves,
among others, reproductive biology, endocrinology,med-
icine, genetics, behavior, developmental biology, and tox-
icology (1). (For a complete list of Signatories and their
Disclosures, see Supplemental Table 1 published on The
Endocrine Society’s Journals Online web site at
http://end.endojournals.org.)
Thousands of published studies have revealed the health
effects of EDCs on wildlife and laboratory animals and,
moreover, have shown associations of EDCs with effects in
humans.Many of these studies have been reviewed recently
by The Endocrine Society, the United Nations Environment
Programme (UNEP) and World Health Organization
(WHO), and other independent scientists (2–5). The conclu-
sions presented in each of these documents are extraordi-
narily consistent: like hormones, EDCsare active at very low
doses and can induce a range of adverse health outcomes,
many of which are not examined in traditional toxicology
assays (1). In sum, these reports point to the conclusion that
EDCs pose a global health threat.
A recent editorial signed by a number of editors of tox-
icology journals argues for the status quo in the regulation
of EDCs (6), despite the large volume of evidence indicat-
ing that current regulations are ineffective in protecting
human populations from these chemicals (4–7). As the
UNEP/WHOreportnotes, the incidenceof chronicdisease
is nowgreater than that of communicable disease;manyof
these diseases have an endocrine basis. Both experimental
animal and epidemiology studies provide plausible causal
links between EDCs andmany of these diseases; for some,
the data are sufficiently robust (8).
The dismissive approach to endocrine disruption sci-
ence put forth by Dietrich et al (6) is unfounded, as it is
neither based on the fundamental principles of how the
endocrine system works and how chemicals can interfere
with its normal function, nor does it consider the conse-
quences of that interference. Their letter also ignores a
growing and rigorous body of literature on both endoge-
nous hormonal and exogenous EDC effects.
Basic scientists, clinical investigators, and physicians
understand that the endocrine system’s functions and re-
sponses change remarkably across the life cycle. Of par-
ticular concern is incontrovertible evidence, published
more than a half century ago (9, 10), that there are critical
life stages, especially during early development,whenhor-
mones dictate the differentiation and development of tis-
sues. Any perturbation of the delicate hormonal balance,
whether due to the absence of natural hormones or the
presence of exogenous hormones, can have irreversible
effects on endocrine-sensitive organs. EDCs are known to
upset this delicate balance.
Dietrich et al (6) also misrepresent the state of science
on thresholds, stating that the evidence “clearly demon-
strates the presence of a threshold for nongenotoxic com-
pounds including EDCs.” Dietrich et al assert that their
position constitutes “common sense” and that the Euro-
pean Commission’s approach departs from common
sense.Theydonot, however, provide scientific support for
this position. Instead, they list several references (11–15)
that, upon examination, do not contain data supporting
their assumption but rather simply assert that the assump-
tion is true. They also fail to address the considerable lit-
erature that speaks against that assumption (eg, Refs 16–
20). Finally, they argue that structuring regulation upon
the assumption of no threshold “will set an unforeseen
precedence [sic].” This is simply and demonstrably not
true. The assumption of no threshold has been widely
used, for many years, in the regulation of genotoxic car-
cinogens, often based on in vitro data. We believe extend-
ing this precedent toEDCs is supportedby the science (19).
Furthermore, we hold that common sense dictates that
policies, particularly those inwhich public health is at stake,
should be based on scientific evidence obtained from the
world’s leading researchers and should derive from a more
evolved,modernunderstandingof thescience, rather thanon
older,outdatedconceptsanddata taught inclassrooms20or
more years ago. The European Commission policy, by that
standard, does represent “common sense.”
Further, the US National Academy of Sciences has con-
cluded that because of the range of susceptibility to environ-
mental chemicals across the population, such as that from
age, preexisting conditions, and genetic variation, and be-
cause therearedocumentedexposures tomultiple chemicals,
including EDCs, in the population, it is more appropriate to
consider lack of thresholds at a population level (16).
Many toxicologists have developed rigorous research
programs on EDCs that incorporate endocrinological
principles, including two former presidents of the Society
of Toxicology, CherylWalker and Linda Birnbaum. They
and many other toxicologists do work in this area and
report results that have contributed to the breadth and
depth of concern about EDCs as a global public health
threat. The ad hominem attacks in Dietrich et al (6) do
nothing to advance science or opportunities to protect
public health;we refer readers to two additional responses
to their editorial that support this point of view (21, 22).
We need the fields of toxicology, endocrinology and other
stakeholders to work together to address these issues, not
engage in recriminations.
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Policymakers in Europe and elsewhere should base their
decisions on science, not on assumptions basedonprinciples
that arose out of research on chemicals that are not EDCs.
The letter by Dietrich et al does the European Commission,
science, including the field of toxicology, and most impor-
tantly, public health, a profound disservice.
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